NEWS AND EVENTS
Chiesi Ventures invest in Aura Bioscience
March 5, 2015
Chiesi Ventures invest in rare optho-oncology company AuraBiosciences. The Boston-based company is focused on the development of drugs using tumor targeted Pseudovirions, synthetic viruses that demonstrate key targeting selectivity for solid tumors and metastases and can efficiently release target molecules within cancerous cells.
Chiesi launches venture fund via collaboration with A. M. Pappas and Associates
September 2, 2014
On September 2, 2014, Chiesi Ventures and A. M. Pappas & Associates announced a strategic collaboration.
With the deal, Chiesi Ventures is able to leverage A. M. Pappas & Associates’ expertise and network to access and assess deals and opportunities, lead investments and manage transactions.
Chiesi Ventures will be attending the Roadman and Renshaw conference, Sept 8-10 in NYC
August 28, 2014
Chiesi Ventures will attend the Roadman and Renshaw conference in New York City, on September 8 -10, 2014. During this period, Chiesi will host a private reception to announce the creation of the fund to other investors in the life science venture capital space.